Investing Profile

Geeta Vemuri

InvestorVCFounder
Founder and Managing Partner at Agent Capital
agentcapital.comBoston, Massachusetts
Photo of Geeta Vemuri, Managing Partner at Agent Capital
Your Intro Paths to Geeta Vemuri

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →

Find Geeta Vemuri on

cb
Current Investing Position
Agent Capital Managing Partner
Investment Range
$250K - $15.0M
Sweet Spot
$7.5M
Investments On Record
11

Geeta Vemuri is on these Sector & Stage Rankings

Pharmaceuticals (Pre-seed)Pharmaceuticals (Series B)Digital Health (Pre-seed)Pharmaceuticals (Series A)Pharmaceuticals (Seed)Health & Hospital Services (Pre-seed)Digital Health (Series B)BioTech (Pre-seed)Health IT (Pre-seed)Health & Hospital Services (Series B)Digital Health (Series A)Digital Health (Seed)Pharmaceuticals (Pre-seed)BioTech (Series B)Health IT (Series B)Health & Hospital Services (Series A)Health IT (Series A)Pharmaceuticals (Series B)Health & Hospital Services (Seed)Health IT (Seed)Pharmaceuticals (Series A)BioTech (Series A)BioTech (Seed)Digital Health (Pre-seed)Pharmaceuticals (Seed)Digital Health (Series B)Health & Hospital Services (Pre-seed)BioTech (Pre-seed)Health IT (Pre-seed)Health & Hospital Services (Series B)Health IT (Series B)BioTech (Series B)BioTech (Series A)Digital Health (Series A)Boston / New EnglandDigital Health (Seed)Health IT (Series A)BioTech (Seed)Health & Hospital Services (Seed)Health & Hospital Services (Series A)Health IT (Seed)

Geeta Vemuri's Investments On Record (8)

CompanyStageDateRound SizeTotal Raised
Cantai Therapeutics
SeedNov 2023$700K
$700K
Vittoria Biotherapeutics
Series UnknownNov 2023$15M
SeedJun 2022$10M
$25M
Carisma Therapeutics
Series CSep 2022$30M
Series BMar 2021$12M
$150M
Co-investors: Dr. Regina Hodits (Wellington Partners), Margarita Chavez (AbbVie Ventures), Peter Dudek (MRL Ventures Fund)
Carbon Biosciences
Series AJun 2022$38M
$38M
Cyrus Biotechnology
Series BDec 2021$18M
$26M
Co-investors: Gus Tai (Trinity Ventures)
Immunitas Therapeutics
Series BAug 2021$58M
$97M
Co-investors: Daniel Coley (Cofounders Capital), Laura Brass (Novartis Venture Fund), Lucio Iannone (Leaps by Bayer), Brian Halak (Domain Associates), Christoph Westphal (Longwood Fund)
Interius BioTherapeutics
Series AMay 2021$76M
Series UnknownMar 2020$6M
$82M
Co-investors: Benjamin Lund (Bain Capital Life Sciences), Daniel Coley (Cofounders Capital)
Pyxis Oncology
Series AJul 2019$22M
$170M
Co-investors: David Steinberg (Longwood Fund), Christopher O'Donnell (Pfizer Venture Investments)